Ethylin Wang Jabs Selected Research

Acrocephalosyndactylia (Apert Syndrome)

1/2019	Nonsyndromic craniosynostosis: novel coding variants.
1/2018	Choanal Atresia and Craniosynostosis: Development and Disease.
6/2014	Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
2/2014	Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice.
5/2013	From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome.
11/2010	Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
3/2010	Brain phenotypes in two FGFR2 mouse models for Apert syndrome.
2/2010	Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.
7/2009	The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect.
7/2008	The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ethylin Wang Jabs Research Topics

Disease

12	Craniosynostoses (Craniosynostosis) 01/2021 - 11/2005
12	Acrocephalosyndactylia (Apert Syndrome) 01/2019 - 12/2003
6	Oculodentodigital Dysplasia 01/2016 - 02/2003
5	Cleft Lip (Harelip) 02/2012 - 04/2007
4	Cleft Palate (Palate, Cleft) 02/2012 - 07/2008
3	Craniofacial Dysostosis (Crouzon Disease) 01/2022 - 01/2013
3	Synostosis 09/2014 - 02/2010
2	congenital fibrosis of the extraocular muscles 12/2021 - 02/2013
2	Craniofacial Abnormalities 01/2020 - 07/2012
2	Congenital Abnormalities (Deformity) 01/2019 - 06/2014
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 05/2013 - 11/2010
2	Van der Woude syndrome 04/2007 - 06/2005
2	Antley-Bixler Syndrome Phenotype 05/2005 - 03/2004
1	Malocclusion (Crossbite) 01/2022
1	Malformations of Cortical Development 12/2021
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Atrophy 01/2020
1	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 01/2018
1	Choanal Atresia 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Neurologic Manifestations (Neurological Manifestations) 01/2015
1	Polydactyly (Polydactylism) 08/2014
1	Triphalangeal Thumb 08/2014
1	Kallmann Syndrome (Kallmann's Syndrome) 02/2013
1	Strabismus (Squint) 02/2013
1	Achondroplasia 01/2013
1	Skin Abnormalities 06/2012
1	Nager type Acrofacial dysostosis 05/2012
1	Genee-Wiedemann syndrome 01/2010
1	Ectromelia (Phocomelia) 07/2008
1	Roberts Syndrome 07/2008
1	Hypersensitivity (Allergy) 07/2008
1	Brachydactyly 02/2007
1	Syndactyly (Polysyndactyly) 02/2007
1	type v Syndactyly 02/2007
1	type 2 Syndactyly 02/2007
1	Keratitis-Ichthyosis-Deafness Syndrome 08/2006
1	Glioma (Gliomas) 02/2006
1	Pterygium 06/2005
1	Popliteal Pterygium Syndrome 06/2005
1	Virus Diseases (Viral Diseases) 06/2005
1	Disorders of Sex Development (Intersexuality) 05/2005
1	Amenorrhea 03/2004
1	Cataract (Cataracts) 07/2003
1	Capillary Hemangioma 07/2003
1	Hypertelorism 07/2003
1	Hyperpigmentation 07/2003

Drug/Important Bio-Agent (IBA)

9	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2022 - 05/2005
5	Connexin 43 (Connexin43)IBA 01/2016 - 02/2003
4	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 02/2007
4	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 01/2016 - 05/2005
3	Proteins (Proteins, Gene)FDA Link 02/2013 - 12/2010
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2013 - 03/2010
2	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 12/2009
2	Amino Acids FDA Link 01/2022 - 02/2014
2	TubulinIBA 12/2021 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2012
2	Ephrin-B1 (Ephrin B1)IBA 01/2019 - 12/2010
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2012
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2014 - 01/2013
2	Interferon Regulatory FactorsIBA 04/2007 - 06/2005
2	ConnexinsIBA 02/2006 - 05/2005
2	Basic Helix-Loop-Helix Transcription FactorsIBA 11/2005 - 12/2003
2	Oxidoreductases (Dehydrogenase)IBA 05/2005 - 03/2004
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2018
1	vosoritideIBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 08/2014
1	Tuberculin (PPD)IBA 08/2014
1	KinesinsIBA 02/2013
1	RNA Precursors (Precursor, mRNA)IBA 05/2012
1	SmokeIBA 02/2012
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 02/2012
1	Bone Morphogenetic Protein 4IBA 01/2012
1	Twist Transcription FactorsIBA 12/2010
1	p38 Mitogen-Activated Protein KinasesIBA 02/2010
1	Dihydroorotate DehydrogenaseIBA 01/2010
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2009
1	NucleotidesIBA 07/2009
1	A-factor (Streptomyces)IBA 07/2008
1	AcetyltransferasesIBA 07/2008
1	HydrogelsIBA 07/2008
1	polyalanineIBA 02/2007
1	Glutamine (L-Glutamine)FDA Link 02/2007
1	Connexin 26IBA 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 06/2005
1	Complementary DNA (cDNA)IBA 06/2005
1	EnzymesIBA 03/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2004

Therapy/Procedure

12	Sutures (Suture) 01/2022 - 07/2003
1	Precision Medicine 01/2020